Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares shot up 27.8% during trading on Wednesday . The company traded as high as GBX 23 ($0.29) and last traded at GBX 23 ($0.29). 113,192 shares traded hands during mid-day trading, a decline of 65% from the average session volume of 318,884 shares. The stock had previously closed at GBX 18 ($0.23).
Celadon Pharmaceuticals Stock Performance
The company has a market cap of £9.48 million, a price-to-earnings ratio of -1.94 and a beta of -0.26. The company has a debt-to-equity ratio of 196.67, a quick ratio of 6.97 and a current ratio of 1.92. The company has a fifty day moving average of GBX 18.61 and a two-hundred day moving average of GBX 27.39.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Recommended Stories
- Five stocks we like better than Celadon Pharmaceuticals
- Bank Stocks – Best Bank Stocks to Invest In
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Upcoming IPO Stock Lockup Period, Explained
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
